A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis-Reference-Cited by-同舟云学术

A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis

Published:2024-03 Issue:3 Volume:12 Page:209-214
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Ho Ken K Y,Fleseriu Maria,Wass John,Katznelson Laurence,Raverot Gerald,Little Andrew S,Castaño Justo P,Reincke Martin,Lopes M Beatriz,Kaiser Ursula B,Chanson Philippe,Gadelha Mônica,Melmed Shlomo

Publisher

Elsevier BV

Reference49 articles.

1. Clinical biology of the pituitary adenoma;Melmed;Endocr Rev,2022

2. Pituitary neoplasm nomenclature workshop: does adenoma stand the test of time?;Ho;J Endocr Soc,2021

3. Overview of the 2022 WHO Classification of pituitary adenomas/pituitary neuroendocrine tumors: clinical practices, controversies, and perspectives;Wan;Curr Med Sci,2022

4. Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification;Ho;Nat Rev Endocrinol,2023

5. Classification, disease, and diagnosis;Jutel;Perspect Biol Med,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 2022 WHO classification of tumors of the pituitary gland: An update on aggressive and metastatic pituitary neuroendocrine tumors;Brain Pathology;2024-09

2. From Nelson’s Syndrome to Corticotroph Tumor Progression Speed: An Update;Experimental and Clinical Endocrinology & Diabetes;2024-07-03

3. Letter to the Editor From Ho and Melmed: Clinical Practice and Nomenclature of Pituitary Neoplasms: Common Sense Must Prevail;The Journal of Clinical Endocrinology & Metabolism;2024-05-14

4. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs;Endocrine-Related Cancer;2024-05-07